21/05/2024 - Press release
A systematic review and meta-analysis of the scientific evidence published between 2000 and 2021 estimates the recurrence risk in people who have suffered a minor stroke, a stroke that does not cause sequelae. The study is published by the Journal of the American Heart Association and includes participation from the Neurology Service of Hospital del Mar. Almost one in ten people who suffer a stroke without sequelae, known as a minor stroke, will experience a second stroke within three months of the first episode. This is established by a recent study led by researchers from the University of Melbourne in Australia, with participation from the Neurology Service of Hospital del Mar. The work, a systematic review and meta-analysis of 14 publications on the subject, is published by the Journal of the American Heart Association. It is the largest study on this type of pathology conducted to date.
16/05/2024 - General information
13th May 2024 - Hospital del Mar Research Institute, Barcelona, Spain 15th May 2024 - Grande Ospedale Metropolitano Niguarda, Milan, Italy Physicians, scientists, health economics researchers, data and communication experts from the Horizon Europe project SAGITTARIUS joined oncology specialists and members of an EU-wide community of cancer centres in Barcelona and Milan to present the SAGITTARIUS clinical study, a new EU-funded clinical trial leveraging the power of tumor genomics and liquid biopsy to guide the post-surgical care of patients with locoregional colon cancer
15/05/2024 - Institutional news
The admission was approved at the meeting of the organization held on April 9th in Mannheim, Germany. The Research Institute of the Hospital del Mar is one of the five new members of the European Leukemia Net, an international network of excellence to promote cooperative research in different types of leukemias. Its admission was approved at the meeting of the organization held on April 9th in Mannheim, Germany. Dr. Blanca Espinet, coordinator of the Translational Research Group in Hematological Neoplasms and head of the Molecular Cytogenetics section of the Pathological Anatomy Service of Hospital del Mar, is the principal investigator representative of the center.
Més informació "The Research Institute of Hospital del Mar joins the European LeukemiaNet."
14/05/2024 - Press release
Individuals hospitalized for acute exacerbations of chronic obstructive pulmonary disease (COPD) exhibit elevated blood levels of proteins that promote blood clotting, according to a study from Hospital del Mar published in ERJ Open Research. This increases their risk of cardiovascular complications. For this reason, the authors of the study recommend that these patients always receive systematic and preventative anticoagulant treatment during their hospital stay. The same study also points out the need for rigorous monitoring of people with COPD who experience three or more exacerbations per year, as their blood protein profile when stable is very similar to that of individuals hospitalized for this condition.
06/05/2024 - Press release
Dr. Torrens is a Professor of Psychiatry, while Dr. Pujol is a Professor of Dermatology. Both at the Department of Medicine and Health Sciences of UPF. Dr. Marta Torrens, emeritus director of Addiction at Hospital del Mar, has been appointed Professor of Psychiatry at the Department of Medicine and Health Sciences of Pompeu Fabra University since April 16, after successfully passing the opposition process. Dr. Torrens also serves as the coordinator of the Addiction Research Group at the center's Research Institute. Dr. Ramon M. Pujol, head of the Dermatology Service at the hospital and coordinator of the Research Group on Inflammatory and Neoplastic Dermatologic Diseases at the Hospital del Mar Research Institute, won the competition for the position of Professor of Dermatology at UPF on April 17.
03/05/2024 - Press release
Natural Killer (NK) cells, when exposed to antibody treatment used against HER2-positive breast cancer, secrete specific types of cytokines that activate the immune response against tumor cells. Researchers have confirmed that patients with NK lymphocytes present in the tumor environment show a better response to treatment, thanks to this mechanism. This confirms the feasibility of using cytokines secreted by NK cells as markers of response to anti-HER2 antibodies with a simple blood test. It also reaffirms various clinical trials using these lymphocytes to bolster treatment in patients with metastatic HER2-positive breast cancer.
30/04/2024 - Institutional news
Researchers from the Neuroscience Research Program, in conjunction with the University of Minnesota in the United States, will conduct the first meta-analysis with individual data on this issue. They will analyze data from more than 30,000 people in the United States and four European countries. The aim is to obtain recommendations so that governments can establish dietary guidelines to prevent the onset of diseases such as Alzheimer's disease. Is there any type of diet that really works to prevent cognitive decline? Despite all the publications on this question, the scientific evidence is not conclusive. For this reason, the Institute for the Advancement of Foord and Nutrition Sciences (IAFNS), in the United States, a body that acts as an advisor to the US government, has commissioned the Hospital del Mar Research Institute and the Epidemiology and Community Health Division of the University of Minnesota School of Public Health to conduct the first meta-analysis with individual data on the question.
19/04/2024 - General information
He is one of the four runner-ups awarded. He won it for his research in the field of neuroscience and cannabinoid drugs. Dr. Arnau Busquets, coordinator of the Cellular Mechanisms in Physiological and Pathological Behavior Research Group at the Hospital del Mar Research Institute, has won one of the runner-up awards at the 60th Anniversary Farmaindustria Young Researchers Prize. The winner of the prize was Cristina Mayor-Ruiz, from the Biomedical Research Institute of Barcelona. The awards were presented on April 18 at the Círculo de Bellas Artes in Madrid.
15/04/2024 - General information
The Reial Acadèmia de Medicina de Catalunya chose, in a plenary session held on April 9, Dr. Manuel Pera as the new full academician of the institution. Dr. Pera, who was already a corresponding academic since 2022, will be attached to the surgery section of the institution. The section chief of the Gastrointestinal Surgery Unit of the Hospital del Mar and researcher at the center's Research Institute, thus becomes one of the sixty full academicians of the institution. The election is made by a vote among the members themselves. The ceremony of entry into the Royal Academy will take place in the coming months.
11/04/2024 - Press release
It has received a grant from the Carlos III Health Institute to be part of the ISCIII platform for the dynamization and innovation of the industrial capacities of the National Health Service. The project of the Innovation and Digital Transformation Unit presented by the Hospital del Mar research institute on the ITEMAS platform for the dynamization and innovation of the industrial capacities of the National Health Service of the Carlos III Health Institute (ITEMAS ISCIII) will receive a grant of about 300.000 euros for its development in the period 2024-2026. The initiative, coordinated by the Parc Taulí Research and Innovation Institute (I3PT), will have 26 innovation support units and more than a hundred collaborators throughout the State.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
